Global Learning Management System (LMS) Market Report 2022
Major players in the Assisted Reproductive Technologies market are Cooper Surgical Inc., Ferring BV, Hamilton Thorne Ltd., Merck KGaA, Genea Limited, California Cryobank, European Sperm Bank, OvaScience Inc.
New York, Jan. 25, 2022 (GLOBE NEWSWIRE) — Reportlinker.com announces the publication of the “Learning Management System (LMS) Global Market Report 2022” – https://www.reportlinker.com/p06221936/?utm_source=GNW
Bloom IVF Center, Vitrolife, FUJIFILM Irvine Scientific Inc., Nidacon International AB, Monash IVF Group Ltd., Cook Medical, INVO Bioscience Inc., Thermo Fisher Scientific, Boston Science Corporation, Anecova, Carolinas Fertility Institute and Microm Ltd.
The global assisted reproductive technologies market is expected to grow from $26.28 billion in 2021 to $31.29 billion in 2022 at a compound annual growth rate (CAGR) of 19.1%. The growth is primarily due to businesses resuming operations and adjusting to the new normal while recovering from the impact of COVID-19, which previously led to restrictive lockdown measures involving social distancing, remote work and the closure of business activities that have resulted in operational challenges. The market is expected to reach $62.05 billion in 2026 with a CAGR of 18.7%.
The Assisted Reproductive Technology (ART) market includes sales of Assisted Reproductive Technology (ART) by entities (organizations, individual traders, and partnerships) that are used for the treatment of egg or embryo infertility. Assisted reproductive technology is based on surgically removing eggs from women’s ovaries and then fusing them with men’s sperm in the laboratory to create embryos.
These embryos are then reinserted into the woman’s body. ART uses donor eggs, donor sperm or previously stored frozen embryos.
The main types of assisted reproductive technology are in vitro fertilization (IVF), artificial insemination (AI-IUI), frozen embryo replacement (FER) and others. In vitro fertilization (IVF) is a complicated operation that involves collecting eggs and fertilizing them with sperm in a laboratory to create embryos.
These embryos are then implanted into the women’s reproductive organs. The different types of procedures include fresh non-donor, fresh donor, frozen donor, frozen non-donor, embryo or egg bank and are used in hospitals, fertility clinics, etc.
Europe was the largest assisted reproductive technology market region in 2021. North America was the second largest assisted reproductive technology market region.
Regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Technological advancements are a key trend gaining popularity in the assisted reproductive technology market. Major companies operating in the field of assisted reproductive technologies are focusing on developing technological solutions to strengthen their position.
For example, in November 2020, NIPD Genetics, a biotechnology company based in Cyprus, launched Amfira PGT based on target capture enrichment technology. Amfira PGT is a preimplantation genetic test that can be used during fertility treatment to improve the chances of getting pregnant and giving birth to a healthy child.
Amfira PGT can be used in in vitro fertilization (IVF) cycles to determine if embryos are chromosomally normal (euploid) and have the best chance of a safe pregnancy and delivery.
The increasing number of infertility cases is expected to favor the assisted reproductive technologies market in the coming years. Infertility is defined as the inability to get pregnant after one year of frequent, unprotected sex.
Infertility affects both men and women and is usually diagnosed by the inability to conceive. Infertility is treated using assisted reproductive technology (ART).
Fertility therapies that work with both a woman’s egg and a man’s sperm are included in this. For example, according to UCLA Health, a US-based healthcare system, in 2020 around 15% of couples worldwide have difficulty conceiving.
Infertile couples are increasingly turning to assisted reproductive technologies (ART), which are increasing by 5-10% each year. Hence, the increasing number of infertility cases is driving the growth of the assisted reproductive technologies market.
In August 2021, Virtus Health Limited, an Australian company offering assisted reproductive technologies, acquired Adora Fertility and Three Day Hospitals from Healius Limited for $45.0 million. This acquisition will help Virtus Health strengthen its in vitro fertilization (IVF) portfolio. Adora Fertility is an Australia-based company that provides assisted reproductive technologies (ART), including IVF (in vitro fertilization) and ICSI (intracytoplasmic sperm injection).
Countries covered in the Assisted Reproductive Technologies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea , the United Kingdom and the United States.
Read the full report: https://www.reportlinker.com/p06221936/?utm_source=GNW
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.
CONTACT: Clare: [email protected] US: (339)-368-6001 Intl: +1 339-368-6001